IRLAB Therapeutics

Major Shareholding Notification • Oct 5, 2020

Issuer IRLAB Therapeutics AB

Holder

196804 Daniel Johnsson

Instrument

Instrument	Aktie SE0012675361
Before the transaction
Shares	2,684,551
Voting rights	2,684,551
Transaction
Reason for major shareholding notification Corporate action
Date	01/10/2020
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	2,690,000
Directly held voting rights	2,690,000
Indirectly held voting rights	0
Percentage
Directly held shares	5.56 %
Directly held voting rights	5.56 %
Indirectly held voting rights	0 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	5.56 %	2,690,000
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total	5.56 %	2,690,000

Group total holdings

Voting rights 2,690,000 Percentage of voting rights 5.56

Notes (other relevant informations according to law)

Hade innehav 2,684,551st då IRLAB den 30/9 flyttades in till NASDAQ från First North. Köpte 5,449 aktier dagen efter. Finns i en ISK-depå hos Nordnet och jag vet ej om jag måste meddela det till er men antog detta...

Published

05/10/2020 23:28

Contact

Name Daniel Johnsson

Phone 0736-876400 Email daniel@exertis.se

CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25